Tadalafil Tablet, Film Coated
Product Images NDC 71205-502

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 71205-502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Tadalafil Figure1)

A set of four line graphs showing blood pressure differences over time. The graphs compare tadalafil versus placebo effects on standing systolic, standing diastolic, supine systolic, and supine diastolic blood pressure measured in mmHg, plotted across 0 to 96 hours.*

FDA Label Image

Figure (Tadalafil Figure2)

Two line graphs depicting the change in systolic blood pressure over 24 hours post-dose. The top graph shows standing systolic blood pressure with two lines comparing Tadalafil 20 mg & doxazosin 8 mg versus placebo & doxazosin 8 mg. The bottom graph shows supine systolic blood pressure over time with the same treatment comparisons.*

FDA Label Image

Figure (Tadalafil Figure3)

A line graph depicting changes in systolic blood pressure (mmHg) over 12 hours after administration of tadalafil or placebo, combined with doxazosin. The x-axis represents time after administration, and the y-axis measures systolic BP. Four groups are shown: 20 mg tadalafil at 08:00, placebo at 08:00, 20 mg tadalafil at 20:00, and placebo at 20:00, all with 8 mg qd doxazosin.*

FDA Label Image

Figure (Tadalafil Figure4)

A graph showing plasma tadalafil concentration (µg/L) over time (hours) for different dosing regimens. The graph includes lines representing a single 20-mg tadalafil dose, a single 5-mg tadalafil dose, and once-daily 5-mg tadalafil following 5 consecutive days of administration, with error bars indicating variability.*

FDA Label Image

Figure 5 (Tadalafil Figure5)

A line graph showing change from baseline in IPSS total score over 12 weeks of treatment, comparing tadalafil 5 mg and placebo. The graph plots duration in weeks on the x-axis and change in IPSS score on the y-axis, illustrating greater improvement with tadalafil 5 mg versus placebo, with statistical significance noted at 12 weeks.*

FDA Label Image

Figure 6 (Tadalafil Figure6)

A line graph comparing the change from baseline in IPSS total score over a 12-week treatment duration between tadalafil 5 mg and placebo. The graph shows a greater decrease in score with tadalafil, indicating improvement, with statistically significant differences (p<0.01) at multiple time points.*

FDA Label Image

Figure 7 (Tadalafil Figure7)

A line graph showing the least-squares mean change from baseline over 26 weeks of therapy comparing Tadalafil/Finasteride and Placebo/Finasteride. The vertical axis represents change from baseline, and the horizontal axis indicates weeks of therapy at 0, 4, 12, and 26. Tadalafil/Finasteride shows a greater negative change compared to Placebo/Finasteride at each time point, with statistical significance indicated at weeks 4, 12, and 26.*

FDA Label Image

Figure 8 (Tadalafil Figure8)

A line graph comparing the change from baseline in IPSS Total Score over 12 weeks for tadalafil 5 mg versus placebo. The x-axis represents treatment duration in weeks, and the y-axis shows the change in IPSS Total Score. Tadalafil shows a greater decrease in score over time compared to placebo, with a statistically significant difference noted at 12 weeks (p<0.01).*

FDA Label Image

71205-502-30 (Tadalafil Label 10mg)

Label for Tadalafil 10 mg film coated tablets by Proficient Rx LP. The label indicates a 30 tablet count with each almond-shaped, yellow biconvex tablet debossed with "FJ3" on one side. Manufactured by Intas Pharmaceuticals Limited, India, it includes storage instructions at 25°C and standard regulatory markings including NDC 71205-502-30 and RX only.*

FDA Label Image

Chemical Structure (Tadalafil Structure)

Chemical structure diagram of Tadalafil, showing the arrangement of atoms and bonds in the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.